Pain stimulates some behaviors (e.g., withdrawal responses) but depresses many other behaviors (e.g., feeding). Pain-stimulated behaviors are widely used in preclinical research on pain and analgesia, but human and veterinary medicine often rely on measures of functional impairment and pain-depressed behavior to diagnose pain or assess analgesic efficacy. In view of the clinical utility of measures of pain-depressed behaviors, our laboratory has focused on the development of methods for preclinical assays of pain-depressed behavior in rodents. The present study compared the effects of a chemical noxious stimulus (IP lactic acid injections) and an opioid analgesic (morphine) administered alone or in combination on the stretching response (a pain-stimulated behavior) and intracranial self-stimulation (ICSS; a behavior that may be depressed by pain) in rats. In the ICSS procedure, rats implanted with electrodes in the lateral hypothalamus responded to electrical stimulation across a range of current frequencies to permit rapid determination of frequency-rate curves and evaluation of curve shifts following treatment. Lactic acid alone produced a concentration-dependent stimulation of stretching and depression of ICSS, expressed as rightward shifts in ICSS frequency-rate curves. Morphine had little effect alone, but it produced a dose-dependent blockade of both acid-stimulated stretching and acid-depressed ICSS. Both lactic acid and morphine were equipotent in the stretching and ICSS procedures. These results suggest that ICSS may be useful as a behavioral baseline for studies of pain-depressed behavior.
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Introduction
Preclinical assays of pain and analgesia necessarily include two elements: (1) a manipulation intended to produce a pain-like state (the independent variable), and (b) measurement of a response presumed to be indicative of that pain-like state (the dependent variable). In recent years, there have been significant advances in the types of manipulations used to model clinically relevant pain states [4,27,37,38]. However, the dependent measures in preclinical assays have been much slower to evolve [5, 35, 37, 49, 50] . The most widely used measures fall into a category that we have described as ''pain-stimulated behaviors," which can be defined as behaviors that increase in rate, frequency or intensity in response to a noxious stimulus [37, 46] . Common examples include withdrawal responses from stimuli that can be escaped (e.g., tail withdrawal from thermal stimuli) or stretching/flinching responses from stimuli that cannot be escaped (e.g., stretching responses elicited by intraperitoneal injection of chemical stimuli).
Although a focus on pain-stimulated behaviors can be useful for many applications, an exclusive reliance on these behaviors as dependent measures can be problematic for at least two reasons. First, drugs or other manipulations may decrease pain-stimulated behaviors not only by producing sensory effects (e.g., true analgesia, defined as a selective decrease in sensitivity to noxious stimuli), but also by producing motor effects (e.g., sedation, paralysis or other effects that decrease a subject's ability to respond). Consequently, results obtained in assays of pain-stimulated behavior may be difficult to interpret, and assays of motor function (e.g., rotarod performance) are often conducted in parallel to aid in characterization of motor effects [44] . Second, pain states that require clinical intervention are often associated with a depression of behavior rather than with a stimulation of behavior, and in humans, pain-related depression of behavior is often accompanied by a co-morbid depression of mood [3, 17, 22, 28] . Indeed, diagnostic tools that measure pain-related depression of behavior and mood
